Microsome-associated lumenal lipid droplets in the regulation of lipoprotein secretion
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Purpose of review Liver is the major organ in mammals that possesses the capacity to release triglyceride within VLDL. VLDL assembly requires apolipoprotein (apo) B-100 with the assistance of microsomal triglyceride transfer protein (MTP), which facilitates the mobilization of triglyceride into the microsomal lumen. Recent experimental evidence has suggested that the lumenal triglyceride associated with endoplasmic reticulum (ER)/Golgi may represent an entity serving as precursors for large VLDL1. Recent findings Under lipid-rich conditions, discrete triglyceride-rich lipidic bodies, termed lumenal lipid droplets, are accumulated in association with ER/Golgi microsomes. Formation of the microsome-associated lumenal lipid droplets (MALD) is dependent on the activity of MTP, and the resulting apoB-free lipidic body is associated with a variety of proteins including apolipoproteins that are components of VLDL. Formation and utilization of MALD during the assembly and secretion of VLDL1 have a profound influence on hepatic cell physiology, such as ER stress responses. Summary This review summarizes current understanding of hepatic triglyceride homeostasis in general, and highlights the functional significance of triglyceride compartmentalization between cytosol and microsomes in particular. Understanding of MALD metabolism may shed new light on the prevention and treatment of liver diseases associated with abnormally elevated intracellular triglycerides.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most de novo synthesized TG is stored in cytosolic LDs and a smaller portion is secreted in the form of VLDL (Fig. 4) [108,109].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [109]
In the citing paper
“Increased FFA flux, as observed in IR states, has been suggested to increase intracellular availability of TG and indirectly stimulate the assembly and secretion of VLDL particles [12,107,109].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [109]
Citations
Cites
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772 · cited 1×
“Recently, two alternative mechanisms, in addition to the well established insulin-dependent or oxysterol-dependent effects on SREBP-1 activation [3], have been postulated.”
BackgroundLisanti, M. P., Scherer, P. E., Vidugiriene, J., Tang, Z., Hermanowski-Vosatka, A., Tu, Y. H., Cook, R. F., & Sargiacomo, M. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.1.111 · Cited by 906
Kammoun, H. L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferré, P., & Foufelle, F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37007 · Cited by 732 · cited 1×
“One mechanism suggests that activation of SREBP-1c is accompanied with ER stress, and overproduction of the molecular chaperone BiP/GRP78 can attenuate SREBP-1c activation and hepatic steatosis [4].”
BackgroundFunctional genomic screen reveals genes involved in lipid-droplet formation and utilization
Guo, Y., Walther, T. C., Rao, M., Stuurman, N., Goshima, G., Terayama, K., Wong, J. S., Vale, R. D., Walter, P., & Farese, R. V. (2008) · Nature · doi:10.1038/nature06928 · Cited by 719
Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300043200 · Cited by 707
Yu, S., Matsusue, K., Kashireddy, P., Cao, W.-Q., Yeldandi, V., Yeldandi, A. V., Rao, M. S., Gonzalez, F. J., & Reddy, J. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210062200 · Cited by 619
Yao, Z. M., & Vance, D. E. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69166-5 · Cited by 618 · cited 1×
“These new discoveries provide evidence that hepatic steatosis is closely related to altered phosphatidylcholine metabolism [9] and may offer an explanation for early observations that choline-deficient and methionine-deficient dietinduced fatty liver [10].”
BackgroundSelf-citationHepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
Zhou, J., Febbraio, M., Wada, T., Zhai, Y., Kuruba, R., He, J., Lee, J. H., Khadem, S., Ren, S., Li, S., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.037 · Cited by 605
Matsusue, K., Haluzik, M., Lambert, G., Yim, S.-H., Gavrilova, O., Ward, J. M., Brewer, B., Reitman, M. L., & Gonzalez, F. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317223 · Cited by 585
Krahmer, N., Guo, Y., Wilfling, F., Hilger, M., Lingrell, S., Heger, K., Newman, H. W., Schmidt-Supprian, M., Vance, D. E., Mann, M., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.013 · Cited by 530
Cited by
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440
Hashidate-Yoshida, T., Harayama, T., Hishikawa, D., Morimoto, R., Hamano, F., Tokuoka, S. M., Eto, M., Tamura-Nakano, M., Yanobu-Takanashi, R., Mukumoto, Y., et al. (2015) · eLife · doi:10.7554/elife.06328 · Cited by 270
“Therefore, the normal luminal transfer of TG is critical in vivo, but factor(s) and environment enabling an efficient transport by MTP remain poorly understood (Yao et al., 2013).”
BackgroundSmagris, E., Gilyard, S., BasuRay, S., Cohen, J. C., & Hobbs, H. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719955 · Cited by 226
Wei, X., Shi, X., Zhong, W., Zhao, Y., Tang, Y., Sun, W., Yin, X., Bogdanov, B., Kim, S., McClain, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055382 · Cited by 94
“Balance between TG synthesis and export is a key determent of hepatic lipid homeostasis [32,33].”
BackgroundTruong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
“Increased FFA flux, as observed in IR states, has been suggested to increase intracellular availability of TG and indirectly stimulate the assembly and secretion of VLDL particles [12,107,109].”
Isoform- and cell-state-specific APOE homeostasis and function
Lindner, K., & Gavin, A.-C. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01470 · Cited by 13
“TAG is first transferred from cytoplasmic to luminal lipid droplets and then loaded onto nascent VLDL particles (Yao et al., 2013).”
Background
Metadata
- Authors
- Yao, Z., Zhou, H., Figeys, D., Wang, Y., & Sundaram, M.
- Affiliations
- University of Ottawa (CA)
- Chinese Academy of Sciences (CN)
- Corresponding author
- Yao, Zemin
- Venue
- Current Opinion in Lipidology
- Published
- 2013-04
- Volume
- 24
- Issue
- 2
- Pages
- 160-170
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W1996151425
- Cited by
- 46
- References
- 53
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 3 · 2014: 6 · 2013: 2
- FWCI
- 0.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Canada Research Chairs
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- VLDL secretion, microsomal triglyceride transfer protein, apolipoprotein B-100, endoplasmic reticulum stress, apolipoproteins
- MeSH terms
- Abetalipoproteinemia, Animals, Cytosol, Endoplasmic Reticulum, Fatty Liver, Homeostasis, Humans, Lipoproteins, VLDL, Liver, Microsomes, Triglycerides, Lipogenesis, Mice, Sterol Regulatory Element Binding Protein 1, Apolipoprotein C-III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.